ALACHUA, Fla., Nov. 7 /PRNewswire-FirstCall/ -- Regeneration Technologies, Inc. (RTI) , the Florida-based processor of orthopedic, cardiovascular and other biologic implants, will be releasing financial results from the third quarter on Wednesday, Nov. 8, 2006 before the market opens.
RTI will hold a live conference call and simultaneous audio web cast on Wednesday, Nov. 8, 2006 at 9:00 a.m. ET to discuss third quarter results. The conference call can be accessed by dialing 888-390-0675, passcode RTIXQ THREE. The web cast can be accessed through the investor section of RTI’s web site at www.rtix.com. A telephone replay of the call will be available through Dec. 8, 2006 and can be accessed by calling 800-871-1323; the replay will also be available at www.rtix.com.
About Regeneration Technologies, Inc.
RTI processes allograft and xenograft tissue into shaped implants for use in orthopedic and other surgeries with a commitment to science, safety and innovation.
RTI also holds patents on the BioCleanse(R) process, the only proven tissue sterilization process validated to eliminate viruses, bacteria, fungi and spores from tissue without impacting the structural or biomechanical integrity of the tissue. The company has distributed more than half a million implants sterilized with the BioCleanse process with zero incidence of infection. RTI is accredited by the American Association of Tissue Banks and was named a 2004 Technology Pioneer by the World Economic Forum.
Except for historical information, any statements made in this press release about the company’s anticipated financial results, future operational results or regulatory approvals are forward-looking statements subject to risks and uncertainties such as those described in the company’s public filings on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results reflected in these forward- looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or by visiting RTI’s web site at www.rtix.com or the SEC’s web site at www.sec.gov.
Regeneration Technologies, Inc.
CONTACT: Wendy Crites Wacker, APR, Corporate Communications ofRegeneration Technologies, Inc., +1-386-418-8888
Web site: http://www.rtix.com//
